Advertisement

Drug Safety

, Volume 14, Issue 2, pp 85–93 | Cite as

Bezoars

Implicated Drugs and Avoidance Strategies
  • Kerry C. Thompson
  • John P. Iredale
Review Articles Drug Experience

Summary

A wide variety of drugs or combinations of drugs have the potential to form bezoars. In the majority of patients presenting with bezoars there is a clear predisposing factor. This article highlights those drugs or groups of drugs which have been implicated in bezoar formation. Although bezoars are rare, it is important that the clinician is aware of the possibility of their development, particularly in susceptible individuals. This is because bezoars often develop in the elderly and in those with serious coexistent disease. They may be difficult to diagnose and recourse to laparotomy is frequently required to treat them. As a result, they are associated with a significant morbidity and mortality.

Keywords

Cystic Fibrosis Adis International Limited Sucralfate Myotonic Dystrophy Sodium Polystyrene Sulfonate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carrougher JG, Barrilleaux CN. Esophageal bezoars: the sucralith. Crit Care Med 1991; 19: 837–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Ahn YH, Maturu P, Steinheber FU, et al. Association of diabetes mellitus with gastric bezoar formation. Arch Intern Med 1987; 147: 527–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Korenman MD, Stubbs MB, Fish JC. Intestinal obstruction from medication bezoars. JAMA 1978; 240 (1): 54–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Brettschneider L, Monafo W, Osborne DP. Intestinal obstruction due to antacid gels. Gastroenterology 1965; 49 (3): 291–4.PubMedGoogle Scholar
  5. 5.
    Sandeman DR, Clements MR, Perrins EJ. Oesophageal obstruction due to hydroscopic gum laxative [letter]. Lancet 1980; i: 364–5.CrossRefGoogle Scholar
  6. 6.
    Sussman S, Goldberg RP, Glotzer DJ. Aluminum hydroxide gel bezoar: CT diagnosis. J Can Assoc Radiol 1985; 36: 148–9.PubMedGoogle Scholar
  7. 7.
    Diettrich NA, Gau FC. Postgastrectomy phytobezoars — endoscopic diagnosis and treatment. Arch Surg 1985; 120 (4): 432–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Robles R, Parrilla P, Escamilla C, et al. Gastrointestinal bezoars. Br J Surg 1994; 81: 1000–1.PubMedCrossRefGoogle Scholar
  9. 9.
    Gebhard RL, Albrecht J. The diet pill that worked [letter]. N Engl J Med 1990; 322: 702.PubMedGoogle Scholar
  10. 10.
    Angueira C, Kadakia S. Esophageal and duodenal bezoars from Perdiem [letter]. Gastrointest Endosc 1993; 39: 110–1.PubMedCrossRefGoogle Scholar
  11. 11.
    Anderson W, Weatherstone G, Veal C. Esophageal medication bezoar in a patient receiving enterai feedings and sucralfate. Am J Gastroenterol 1989; 84: 205–6.PubMedGoogle Scholar
  12. 12.
    Grosskopf I, Streifler J, Garty M, et al. Esophageal bezoar in progressive systemic sclerosis [letter]. J Clin Gastroenterol 1986; 8: 695–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Lange V. Gastric phytobezoar: an endoscopic technique for removal. Endoscopy 1986; 18: 195–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Mamel JJ. Bezoar of the esophagus occurring in achalasia. Gastrointest Endosc 1984; 30: 317–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Tsianos EB, Drosos AA. Gastroscopic removal of a phytobezoar formed in a patient with mixed connective tissue disease. Endoscopy 1988; 20: 122–3.PubMedCrossRefGoogle Scholar
  16. 16.
    Algozzine GJ, Hill G, Scoggins WG, et al. Sucralfate bezoar. N Engl J Med 1983; 309: 1387.PubMedGoogle Scholar
  17. 17.
    Kuiper D. Gastric bezoar in a patient with myotonic dystrophy. Am J Dig Dis 1971; 16: 529–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Deutsch AA, Gutman H, Mor C, et al. Gastric cancer bezoar. J R Coll Surg Edinb 1987; 32: 165–6.PubMedGoogle Scholar
  19. 19.
    Schwab KS, Cheng EH. ‘Postgastrectomy’ bezoar secondary to gastric cancer. J Clin Gastroenterol 1993; 16: 45–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Van Thiel DH, deBeile RC, Painter TD, et al. Phytobezoar occurring as a complication of gastric carcinoma. Gastroenterology 1975; 68 (5 Pt 1): 1292–6.PubMedGoogle Scholar
  21. 21.
    Canivet B, Creisson G, Freychet P, et al. Fibre, diabetes, and risk of bezoar [letter]. Lancet 1980; ii (8199): 862.CrossRefGoogle Scholar
  22. 22.
    Brady PG. Gastric phytobezoars consequent to delayed gastric emptying. Gastrointest Endosc 1978; 24: 159–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Calabuig R, Navarro S, Carrio I, et al. Gastric emptying and bezoars. Am J Surg 1989; 157: 287–90.PubMedCrossRefGoogle Scholar
  24. 24.
    Tohdo H, Haruma K, Kitadai Y, et al. Gastric emptying and bezoars in Japanese. Report of five cases. Dig Dis Sci 1993; 38: 1422–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Potyk D. Intestinal obstruction from impacted antacid tablets. N Engl J Med 1970; 283: 134–45.PubMedCrossRefGoogle Scholar
  26. 26.
    Townsend CM, Remmers AR, Sarles HE, et al. Intestinal obstruction from medication bezoar in patients with renal failure. N Engl J Med 1973; 20: 1058–9.CrossRefGoogle Scholar
  27. 27.
    Shaffer JL, Higham C, Turnberg LA. Hazards of slow-release preparations in patients with bowel strictures [letter]. Lancet 1980; ii (8192): 487.CrossRefGoogle Scholar
  28. 28.
    Huizinga WK, Nirmul D, Domingo Z, et al. Late presentation of small bowel injury — hypoproteinaemia, anaemia and obstruction. A report of 2 cases. S Afr Med J 1988; 73 (4): 251–2.PubMedGoogle Scholar
  29. 29.
    Thornley Brown D, Galla JH, Williams PD, et al. Lithium toxicity associated with a trichobezoar. Ann Intern Med 1992; 116: 739–40.PubMedGoogle Scholar
  30. 30.
    Buckley N, Dawson AH, Howarth D, et al. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust 1993; 158: 202–4.PubMedGoogle Scholar
  31. 31.
    Rankin RJ, Edwards IR. Overdose of sustained release verapamil [letter]. NZ Med J 1990; 103: 165.Google Scholar
  32. 32.
    Spiller HA, Meyers A, Ziemba T, et al. Delayed onset of cardiac arrhythmias from sustained release verapamil. Ann Emerg Med 1991; 20: 201–3.PubMedCrossRefGoogle Scholar
  33. 33.
    Portuguez-Malavasi A, Aranda JV. Antacid bezoar in a newborn. Pediatrics 1979; 63: 679–80.PubMedGoogle Scholar
  34. 34.
    Nichols Jr TW. Phytobezoar formation: a new complication of cimetidine therapy. Ann Intern Med 1981; 95 (1): 70.PubMedGoogle Scholar
  35. 35.
    Hurley JK. Bowel obstruction occurring in a child during treatment with aluminium hydroxide gel. J Pediatr 1978; 92 (4): 592–3.PubMedCrossRefGoogle Scholar
  36. 36.
    Nichols Jr TW. Cimetidine and phytobezoars [letter]. Lancet 1978; ii: 1263.CrossRefGoogle Scholar
  37. 37.
    Burruss GL, Van Voorst SJ, Crawford AJ, et al. Small bowel obstruction from an antacid bezoar: a ranitidine-antacid interaction? South Med J 1986; 79: 917–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Frohna WJ. Metamucil bezoar: an unusual cause of small bowel obstruction [letter]. Am J Emerg Med 1992; 10: 393–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Perez Piqueras J, Silva C, Jaqueti J, et al. Endoscopic diagnosis and treatment of an esophageal bezoar resulting from bulk laxative ingestion. Endoscopy 1994; 26: 710.PubMedCrossRefGoogle Scholar
  40. 40.
    Cohen MI, Winslow PR, Boley SJ. Intestinal obstruction associated with cholestyramine therapy. N Engl J Med 1969; 280 (23): 1285–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Lloyd-Still JD. Cholestyramine therapy and intestinal obstruction in infants. Pediatrics 1977; 59: 626–7.PubMedGoogle Scholar
  42. 42.
    Prisant LM, Carr AA, Bottini PB, et al. Nifedipine GITS (gastrointestinal therapeutic system) bezoar. Arch Intern Med 1991; 151: 1868–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Stack PE, Patel NR, Young MF, et al. Pharmacobezoars — the irony of the antidote: first case report of nifedipine XL bezoar. J Clin Gastroenterol 1994; 19: 264–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Shepherd MF. Bezoar formed by fragments of extended-release nifedipine tablets. Clin Pharm 1993; 12: 849–52.PubMedGoogle Scholar
  45. 45.
    Bernstein G, Jehle D, Bernaski E, et al. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation. Ann Emerg Med 1992; 21: 1388–90.PubMedCrossRefGoogle Scholar
  46. 46.
    Shueke M, Mihas AA. Esophageal bezoar due to sucralfate [letter]. Endoscopy 1991; 23: 305–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Irgau I, Fulda GJ. Esophageal obstruction secondary to concretions of tube-feeding formula. Crit Care Med 1995; 23: 208–10.PubMedCrossRefGoogle Scholar
  48. 48.
    McIvor AC, Meguid MM, Curtas S, et al. Intestinal obstruction from cecal bezoar; a complication of fiber-containing tube feedings. Nutrition 1990; 6: 115–7.PubMedGoogle Scholar
  49. 49.
    Hart R, Bernard L, Gholson C. Esophageal obstruction caused by sucralfate impaction. Gastrointest Endosc 1989; 35: 474.PubMedCrossRefGoogle Scholar
  50. 50.
    Reddy AN. Sucralfate gastric bezoar. Gastroenterology 1986; 81: 149–50.Google Scholar
  51. 51.
    Baum J. Enteric-coated aspirin and the problem of gastric retention [letter]. J Rheumatol 1984; 11: 250–1.PubMedGoogle Scholar
  52. 52.
    Bogacz K, Caldron P. Enteric-coated aspirin bezoar: elevation of serum salicylate level by barium study. Case report and review of medical management. Am J Med 1987; 83: 783–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Landsman I, Bricker JT, Reid BS, et al. Emergency gastrotomy: treatment of choice for iron bezoar. J Pediatr Surg 1987; 22: 184–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Vickery RE. Unusual complication of excessive ingestion of vitamin C tablets. Int Surg 1973; 58: 422–3.PubMedGoogle Scholar
  55. 55.
    Hunt Fugate AK, Schmidt HJ. Cecal vitamin bezoar formation inducing abdominal discomfort. Ann Pharmacother 1992; 26: 485–7.PubMedGoogle Scholar
  56. 56.
    Hsu HH, Grove WE, Mindulzun R, et al. Gastric bezoar caused by lecithin: an unusual complication of health faddism. Am J Gastroenterol 1992; 87: 794–6.PubMedGoogle Scholar
  57. 57.
    Silbergleit R, Lee DC. Bowel obstruction and radiopaque vitamin B12 ‘pseudobezoar’ [letter]. Am J Emerg Med 1995; 13: 112–3.PubMedCrossRefGoogle Scholar
  58. 58.
    Berman L, Briggs R, Thomas RM. Ion-exchange resin bezoar in a neonate. Clin Radiol 1986; 37: 297–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Fleisher DS. Hyperkalaemia in infants and children. J Pediatr 1961; 58 (4): 486–92.PubMedCrossRefGoogle Scholar
  60. 60.
    Fildes RD, Springate JE, Jewett T, et al. Colonic intussusception secondary to a calcium phosphate bezoar in a child receiving calcium carbonate for hyperphosphatemia. J Pediatr Surg 1989; 24: 1195–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Ohlsson A, Hosking M. Complications following oral administration of exchange resins in extremely low-birth-weight infants. Eur J Pediatr 1987; 146: 571–4.PubMedCrossRefGoogle Scholar
  62. 62.
    Ray MJ, Radin DR, Condie JD, et al. Charcoal bezoar. Small-bowel obstruction secondary to amitriptyline overdose therapy [published erratum appears in Dig Dis Sci 1988 Oct; 33 (10): 1344]. Dig Dis Sci 1988; 33: 106–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Schwartz HS. Acute meprobamate poisoning with gastrotomy and removal of drug-containing mass. N Engl J Med 1976; 1177–8.Google Scholar
  64. 64.
    Jenis EH, Payne RJ, Goldbaum LR. Acute meprobamate poisoning: a fatal case following a lucid interval. JAMA 1969; 207: 361–2.PubMedCrossRefGoogle Scholar
  65. 65.
    Meprobamate and bezoar formation [letter]. Ann Emerg Med 1987; 16: 472–3.Google Scholar
  66. 66.
    Schwarzenberg SJ, Freese DK, Payne WD, et al. Gastric bezoar after hepatic transplantation. J Pediatr Gastroenterol Nutr 1989; 9: 119–22.PubMedCrossRefGoogle Scholar
  67. 67.
    Davion T, Delamarre J, Reix N, et al. Gastric bezoar: another side effect of endoscopic variceal sclerotherapy. Scand J Gastroenterol 1989; 24: 818–20.PubMedCrossRefGoogle Scholar
  68. 68.
    Meeroff JC, Squires PA, Grasman K. Gastric lupinoma: a new variety of phytobezoar. Am J Gastroenterol 1989; 84: 650–2.PubMedGoogle Scholar
  69. 69.
    Khoshoo V, Udall Jr JN. Meconium ileus equivalent in children and adults. Am J Gastroenterol 1994; 89: 153–7.PubMedGoogle Scholar
  70. 70.
    Mulherin D, Fitzgerald MX. Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis. Lancet 1990; 335 (8688): 552.PubMedCrossRefGoogle Scholar
  71. 71.
    Mitchell EA, White PR, Elliot RB. Meconium ileus equivalent in a child with cystic fibrosis taking cimetidine. NZ Med J 1980; 92: 155–6.Google Scholar
  72. 72.
    Smyth RL, van Velzen D, Smyth AR, et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 343: 85–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Jones R, Franklin K, Spicer R, et al. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes [letter]. Lancet 1995; 346: 499.PubMedCrossRefGoogle Scholar
  74. 74.
    van Velzen D. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes [letter]. Lancet 1995; 346 (8973): 499–500.PubMedCrossRefGoogle Scholar
  75. 75.
    Walker Renard P. Update on the medicinal management of phytobezoars. Am J Gastroenterol 1993; 88: 1663–6.PubMedGoogle Scholar
  76. 76.
    Kuo JY, Mo LR, Tsai CC, et al. Endoscopic fragmentation of gastric phytobezoar by electrohydraulic lithotripsy. Gastrointest Endosc 1993; 39: 706–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Lubke HJ, Winkelmann RS, Berges W, et al. Gastric phytobezoar: endoscopic removal using the gallstone lithotripter. Z Gastroenterol 1988; 26: 393–6.PubMedGoogle Scholar
  78. 78.
    Benes J, Chmel J, Jodl J, et al. Treatment of a gastric bezoar by extracorporeal shock wave lithotripsy. Endoscopy 1991; 23: 346–8.PubMedCrossRefGoogle Scholar
  79. 79.
    Buckley N, Dawson A. Whole-bowel irrigation for theophylline overdose [letter]. Ann Emerg Med 1993; 22: 1774.PubMedCrossRefGoogle Scholar
  80. 80.
    Assalia A, Schein M, Kopelman D, et al. Therapeutic effect of oral Gastrografin in adhesive, partial small-bowel obstruction: a prospective randomized trial. Surgery 1994; 115: 433–7.PubMedGoogle Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Kerry C. Thompson
    • 1
  • John P. Iredale
    • 1
  1. 1.University of SouthamptonSouthamptonEngland

Personalised recommendations